The foundation of the material was component: Hyaluronic acid and polyiliz. Polyilized, it effectively binds nucleic acids, but may be toxic and does not release the load inside the cell. Hyaluronic acid, the natural component of human tissues, solves these problems. Reduces toxicity and helps to release the therapeutic agent at the right time.
The new polymer, called ha-g-Clys, is independently nanoparticles. These particles can give genetic material or small interferg RNA (Sirna) to the cells that inhibit the development of the disease. The drug based on this can be applied intravenously or intravenously.
For synthesis, method click-cemist was used. This approach led to the high accuracy of the assembly of molecules, the amount of minimum impurities and the simplicity of cleaning the final product. In terms of activity, development is not lower than existing commercial distribution systems.
Source: Ferra
I am a professional journalist and content creator with extensive experience writing for news websites. I currently work as an author at Gadget Onus, where I specialize in covering hot news topics. My written pieces have been published on some of the biggest media outlets around the world, including The Guardian and BBC News.
